Your browser doesn't support javascript.
loading
Structures of α-synuclein filaments from multiple system atrophy.
Schweighauser, Manuel; Shi, Yang; Tarutani, Airi; Kametani, Fuyuki; Murzin, Alexey G; Ghetti, Bernardino; Matsubara, Tomoyasu; Tomita, Taisuke; Ando, Takashi; Hasegawa, Kazuko; Murayama, Shigeo; Yoshida, Mari; Hasegawa, Masato; Scheres, Sjors H W; Goedert, Michel.
  • Schweighauser M; MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Shi Y; MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Tarutani A; Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Kametani F; Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
  • Murzin AG; Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Ghetti B; MRC Laboratory of Molecular Biology, Cambridge, UK.
  • Matsubara T; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Tomita T; Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
  • Ando T; Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
  • Hasegawa K; Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Murayama S; Division of Neurology, Sagamihara National Hospital, Sagamihara, Japan.
  • Yoshida M; Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
  • Hasegawa M; Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan.
  • Scheres SHW; Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Goedert M; MRC Laboratory of Molecular Biology, Cambridge, UK. scheres@mrc-lmb.cam.ac.uk.
Nature ; 585(7825): 464-469, 2020 09.
Article en En | MEDLINE | ID: mdl-32461689
ABSTRACT
Synucleinopathies, which include multiple system atrophy (MSA), Parkinson's disease, Parkinson's disease with dementia and dementia with Lewy bodies (DLB), are human neurodegenerative diseases1. Existing treatments are at best symptomatic. These diseases are characterized by the presence of, and believed to be caused by the formation of, filamentous inclusions of α-synuclein in brain cells2,3. However, the structures of α-synuclein filaments from the human brain are unknown. Here, using cryo-electron microscopy, we show that α-synuclein inclusions from the brains of individuals with MSA are made of two types of filament, each of which consists of two different protofilaments. In each type of filament, non-proteinaceous molecules are present at the interface of the two protofilaments. Using two-dimensional class averaging, we show that α-synuclein filaments from the brains of individuals with MSA differ from those of individuals with DLB, which suggests that distinct conformers or strains characterize specific synucleinopathies. As is the case with tau assemblies4-9, the structures of α-synuclein filaments extracted from the brains of individuals with MSA differ from those formed in vitro using recombinant proteins, which has implications for understanding the mechanisms of aggregate propagation and neurodegeneration in the human brain. These findings have diagnostic and potential therapeutic relevance, especially because of the unmet clinical need to be able to image filamentous α-synuclein inclusions in the human brain.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encéfalo / Cuerpos de Inclusión / Atrofia de Múltiples Sistemas / Microscopía por Crioelectrón / Alfa-Sinucleína Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Encéfalo / Cuerpos de Inclusión / Atrofia de Múltiples Sistemas / Microscopía por Crioelectrón / Alfa-Sinucleína Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article